caprylates has been researched along with MPTP Neurotoxicity Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araki, T; Kato, H; Kurosaki, R; Oki, C | 1 |
Araki, T; Kato, H; Oki, C; Shimoda, T; Watanabe, Y; Yokoyama, H | 1 |
2 other study(ies) available for caprylates and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Microglia; Movement Disorders; MPTP Poisoning; Neurons; Neuroprotective Agents; S100 Proteins | 2004 |
Delayed treatment with arundic acid reduces the MPTP-induced neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Caprylates; Corpus Striatum; DNA-Binding Proteins; Dopamine; Drug Evaluation, Preclinical; Glial Fibrillary Acidic Protein; Intermediate Filament Proteins; Lectins; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Nestin; Neurons; Neuroprotective Agents; Nuclear Proteins; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine 3-Monooxygenase | 2008 |